CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) Tuesday said second-quarter loss widened to $159 million or $0.68 per share from $57.17 million or $0.26 per share in the same period last year.
Adjusted loss for the quarter was $142 million or $0.61 per share. On average, 16 analysts polled by Thomson Reuters expected the company to earn $0.72 per share. Analysts' estimates typically exclude special items.
Revenues decreased to $138.42 million from $310.75 million last year. Analysts expected revenues of $132.06 million.
Looking ahead to the fiscal 2014, the company has forecast adjusted revenues in the range of $520 million to $550 million. Analysts expected revenues of $132.06 million.
Copyright RTT News/dpa-AFX